We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+2.89%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$176M
AUM Growth
+$2.67M
Cap. Flow
-$1.17M
Cap. Flow %
-0.67%
Top 10 Hldgs %
23.17%
Holding
96
New
3
Increased
25
Reduced
36
Closed
1

Top Buys

Rank Stock Value
1
HWM icon
Howmet Aerospace
HWM
+$1.34M
2
IYH icon
iShares US Healthcare ETF
IYH
+$399K
3
BA icon
Boeing
BA
+$219K
4
VZ icon
Verizon
VZ
+$78K
5
KO icon
Coca-Cola
KO
+$59.9K

Top Sells

Rank Stock Value
1
AA icon
Alcoa
AA
+$1.84M
2
MDT icon
Medtronic
MDT
+$300K
3
ABT icon
Abbott
ABT
+$240K
4
QCOM icon
Qualcomm
QCOM
+$202K
5
MSFT icon
Microsoft
MSFT
+$180K

Sector Composition

Rank Sector Weight
1 Industrials 17.49%
2 Technology 12.85%
3 Financials 12.7%
4 Healthcare 9.77%
5 Consumer Staples 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSA icon
26
Comcast
CMCSA
$80.9B
$3.04M 1.73%
88,136
-50
-0.1% -$1.67K
LH icon
27
Labcorp
LH
$24.7B
$3.02M 1.72%
27,355
+396
+1% +$44K
IEMG icon
28
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$3.01M 1.71%
70,987
-298
-0.4% -$13.1K
BNY
29
Bank of New York Mellon
BNY
$107B
$2.87M 1.63%
60,570
+250
+0.4% +$11.3K
PG icon
30
Procter & Gamble
PG
$346B
$2.76M 1.57%
32,882
+135
+0.4% +$11.5K
COP icon
31
ConocoPhillips
COP
$141B
$2.71M 1.54%
54,111
-1,620
-3% -$74.7K
OMC icon
32
Omnicom Group
OMC
$23.5B
$2.71M 1.54%
31,884
-130
-0.4% -$10.9K
STT icon
33
State Street
STT
$50.7B
$2.66M 1.51%
34,246
-410
-1% -$30.9K
IVV icon
34
iShares Core S&P 500 ETF
IVV
$869B
$2.61M 1.49%
11,607
+16
+0.1% +$3.52K
GOOGL icon
35
Alphabet (Google) Class A
GOOGL
$3.99T
$2.58M 1.47%
65,240
+1,400
+2% +$56K
CL icon
36
Colgate-Palmolive
CL
$73.6B
$2.57M 1.46%
39,295
+180
+0.5% +$12.3K
MDT icon
37
Medtronic
MDT
$108B
$2.52M 1.43%
35,320
-3,824
-10% -$300K
CVS icon
38
CVS Health
CVS
$137B
$2.48M 1.41%
31,377
+520
+2% +$42.1K
IEFA icon
39
iShares Core MSCI EAFE ETF
IEFA
$188B
$2.37M 1.35%
44,261
-56
-0.1% -$3.01K
SPY icon
40
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$2.35M 1.34%
10,534
BBH icon
41
VanEck Biotech ETF
BBH
$397M
$2.26M 1.28%
20,973
-495
-2% -$53.8K
USB icon
42
US Bancorp
USB
$98.9B
$2.21M 1.26%
43,045
+320
+0.7% +$15.2K
ABT icon
43
Abbott
ABT
$182B
$2.18M 1.24%
56,672
-6,055
-10% -$240K
VZ icon
44
Verizon
VZ
$198B
$2.11M 1.2%
39,594
+1,560
+4% +$78K
HYG icon
45
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$1.96M 1.12%
22,700
+95
+0.4% +$8.18K
PX
46
DELISTED
Praxair Inc
PX
$1.94M 1.1%
16,565
+140
+0.9% +$16.6K
VB icon
47
Vanguard Small-Cap ETF
VB
$79.9B
$1.88M 1.07%
14,540
-490
-3% -$60.8K
OIH icon
48
VanEck Oil Services ETF
OIH
$2.06B
$1.83M 1.04%
2,745
-12
-0.4% -$7.46K
T icon
49
AT&T
T
$167B
$1.7M 0.97%
53,039
MOS icon
50
The Mosaic Company
MOS
$7.1B
$1.59M 0.9%
54,080
-1,640
-3% -$44K

Similar funds

Boston Research & Management's Q4 2016 Portfolio in Review

As of Q4 2016, Boston Research & Management held 96 positions worth $176M, up 1.5% from $173M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2016: portfolio turnover was 4.2%. Boston Research & Management opened 3 new positions and exited 1, leaving the 96-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Boston Research & Management's largest Q4 2016 buy was Howmet Aerospace: 89,441 shares worth $1.27M.
  • Boston Research & Management added most to Verizon in Q4 2016, an estimated $78K increase.
  • Boston Research & Management's biggest Q4 2016 reduction was Alcoa, cutting an estimated $1.84M.
  • Boston Research & Management fully exited Qualcomm in Q4 2016, selling an estimated $202K.
  • Boston Research & Management's ten largest holdings make up 23% of its $176M portfolio in Q4 2016.
  • Boston Research & Management opened 3 new positions and closed 1 in Q4 2016.
  • Boston Research & Management's portfolio value rose 1.5% quarter-over-quarter to $176M.

Based on Boston Research & Management's 13F filing for Q4 2016, filed 9 Feb 2017.